Evidence map›Paper›PMID 35535393›Full record

ArticleJournal of clinical laboratory analysis2022

Evaluation of conventional and point-of-care real-time RT-PCR tests for the detection of SARS-CoV-2 through a pooled testing strategy.

Ji-Rong Yang, Chuan-Yi Kuo, Hsiang-Yi Huang, I-Ling Yu, Chih-Tsun Hsieh, Bao-Shan Chen, Ming-Tsan Liu

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ji-Rong YangCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.ORCID https://orcid.org/0000-0003-2462-2149
Chuan-Yi KuoCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.
Hsiang-Yi HuangCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.
I-Ling YuCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.
Chih-Tsun HsiehCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.
Bao-Shan ChenCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.
Ming-Tsan LiuCenter for Diagnostics and Vaccine Development, Centers for Disease Control, Taipei, Taiwan.ORCID https://orcid.org/0000-0003-3152-2859
Development Center for Biotechnology · TW

Funding

Ministry of Health and Welfare, TaiwanTaiwan Centers for Disease Control MOHW110-CDC-C-315-124302
6 · The paper itself

Abstract

backgroundThe rapid identification and isolation of individuals infected with SARS-CoV-2 are fundamental countermeasures for the efficient control of the COVID-19 pandemic, which has affected millions of people around the world. Real-time RT-PCR is one of the most commonly applied reference methods for virus detection, and the use of pooled testing has been proposed as an effective way to increase the throughput of routine diagnostic tests. However, the clinical applicability of different types of real-time RT-PCR tests in a given group size remains inconclusive due to inconsistent regional disease prevalence and test demands.

methodsIn this study, the performance of one dual-target conventional and two point-of-care real-time RT-PCR tests in a 5-specimen pooled testing strategy for the detection of SARS-COV-2 was evaluated.

resultsWe demonstrated the proof of concept that all of these real-time RT-PCR tests could feasibly detect SARS-CoV-2 from nasopharyngeal and oropharyngeal specimens that contain viral RNA loads in the range of 3.48 × 10

conclusionOur findings support the feasibility of using real-time RT-PCR tests developed as a variety of platforms in routine laboratory detection of suspected COVID-19 cases through a pooled testing strategy that is beneficial to increasing the daily diagnostic capacity.

Indexed as

COVID-19SARS-CoV-2HumansPandemicsPoint-of-Care SystemsPoint-of-Care TestingReverse Transcriptase Polymerase Chain ReactionSensitivity and Specificitypoint-of-carepooled testingreal-time RT-PCRSARS-CoV-2

Identifiers

PMID35535393
PMCPMC9169176
OpenAlexW4229447264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.